Syros Pharmaceuticals (SYRS) Q1 2023 Earnings

10MayConfirmed
Aug 22
Nov 22
Q4 2022
Q1 2023
-5.4
-3.66
-1.91
-0.17

Details

Expected EPS
-1.09
Actual EPS
-0.85
Surprise EPS
0.24
Surprise Percent
+22.02%

Description

Syros Pharmaceuticals (SYRS) has reported earnings of -0.85 per share for Q1 2023.

0 Comments

Share your thoughts